Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myeloma.
Kostopoulos IV, Ntanasis-Stathopoulos I, Rousakis P, Malandrakis P, Panteli C, Eleutherakis-Papaiakovou E, Angelis N, Spiliopoulou V, Syrigou RE, Bakouros P, Dimitrakopoulou G, Fotiou D, Migkou M, Kanellias N, Paschalidis N, Gavriatopoulou M, Kastritis E, Dimopoulos MA, Tsitsilonis OE, Terpos E.
Kostopoulos IV, et al. Among authors: paschalidis n.
Am J Hematol. 2024 Oct;99(10):1887-1896. doi: 10.1002/ajh.27414. Epub 2024 Jun 11.
Am J Hematol. 2024.
PMID: 38860642